相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。The efficacy and safety of low-dose rituximab in immune thrombocytopenia: a systematic review and meta-analysis
Yunjie Li et al.
PLATELETS (2019)
Immune Thrombocytopenia
Nichola Cooper et al.
NEW ENGLAND JOURNAL OF MEDICINE (2019)
American Society of Hematology 2019 guidelines for immune thrombocytopenia
Cindy Neunert et al.
BLOOD ADVANCES (2019)
Splenectomy for immune thrombocytopenia: down but not out
Shruti Chaturvedi et al.
BLOOD (2018)
Rituximab in immune thrombocytopenia: gender, age, and response as predictors of long-term response
Miriam Marangon et al.
EUROPEAN JOURNAL OF HAEMATOLOGY (2017)
The effect of rituximab on anti-platelet autoantibody levels in patients with immune thrombocytopenia
Donald M. Arnold et al.
BRITISH JOURNAL OF HAEMATOLOGY (2017)
Lack of detectable platelet autoantibodies is correlated with nonresponsiveness to rituximab treatment in ITP patients
Leendert Porcelijn et al.
BLOOD (2017)
Pathogenesis of immune thrombocytopenia
Sylvain Audia et al.
AUTOIMMUNITY REVIEWS (2017)
Severe bleeding events in adults and children with primary immune thrombocytopenia: a systematic review
C. Neunert et al.
JOURNAL OF THROMBOSIS AND HAEMOSTASIS (2015)
Rituximab as second-line treatment for adult immune thrombocytopenia (the RITP trial): a multicentre, randomised, double-blind, placebo-controlled trial
Waleed Ghanima et al.
LANCET (2015)
Safety and efficacy of rituximab in adult immune thrombocytopenia: results from a prospective registry including 248 patients
Mehdi Khellaf et al.
BLOOD (2014)
A multi-centre, single-arm, open-label study evaluating the safety and efficacy of fixed dose rituximab in patients with refractory, relapsed or chronic idiopathic thrombocytopenic purpura (R-ITP1000 study)
Huyen Tran et al.
BRITISH JOURNAL OF HAEMATOLOGY (2014)
Rituximab and three dexamethasone cycles provide responses similar to splenectomy in women and those with immune thrombocytopenia of less than two years duration
James B. Bussel et al.
HAEMATOLOGICA (2014)
Understanding why patients with immune thrombocytopenia are deeply divided on splenectomy
Karen K. W. Wang et al.
HEALTH EXPECTATIONS (2014)
Cost per responder associated with romiplostim and rituximab treatment for adult primary immune thrombocytopenia in France
L. Chiche et al.
TRANSFUSION CLINIQUE ET BIOLOGIQUE (2014)
Efficacy and safety of rituximab given at 1,000 mg on days 1 and 15 compared to the standard regimen to treat adult immune thrombocytopenia
Matthieu Mahevas et al.
AMERICAN JOURNAL OF HEMATOLOGY (2013)
Rituximab and dexamethasone vs dexamethasone monotherapy in newly diagnosed patients with primary immune thrombocytopenia
Sif Gudbrandsdottir et al.
BLOOD (2013)
Long-term follow-up analysis after rituximab salvage therapy in adult patients with immune thrombocytopenia
Francesco Zaja et al.
AMERICAN JOURNAL OF HEMATOLOGY (2012)
A pilot randomized trial of adjuvant rituximab or placebo for nonsplenectomized patients with immune thrombocytopenia
Donald M. Arnold et al.
BLOOD (2012)
How I treat immune thrombocytopenia: the choice between splenectomy or a medical therapy as a second-line treatment
Waleed Ghanima et al.
BLOOD (2012)
Outcomes 5 years after response to rituximab therapy in children and adults with immune thrombocytopenia
Vivek L. Patel et al.
BLOOD (2012)
Platelet-associated antibodies, cellular immunity and FCGR3a genotype influence the response to rituximab in immune thrombocytopenia
Nichola Cooper et al.
BRITISH JOURNAL OF HAEMATOLOGY (2012)
Rituximab before splenectomy in adults with primary idiopathic thrombocytopenic purpura: a meta-analysis
Sophie Auger et al.
BRITISH JOURNAL OF HAEMATOLOGY (2012)
The American Society of Hematology 2011 evidence-based practice guideline for immune thrombocytopenia
Cindy Neunert et al.
BLOOD (2011)
Low-dose rituximab combined with short-term glucocorticoids up-regulates Treg cell levels in patients with immune thrombocytopenia
Zhenyu Li et al.
INTERNATIONAL JOURNAL OF HEMATOLOGY (2011)
International consensus report on the investigation and management of primary immune thrombocytopenia
Drew Provan et al.
BLOOD (2010)
Dexamethasone plus rituximab yields higher sustained response rates than dexamethasone monotherapy in adults with primary immune thrombocytopenia
Francesco Zaja et al.
BLOOD (2010)
Low-dose rituximab in adult patients with primary immune thrombocytopenia
Francesco Zaja et al.
EUROPEAN JOURNAL OF HAEMATOLOGY (2010)
Repeated courses of Rituximab in chronic ITP: Three different regimens
Aisha Hasan et al.
AMERICAN JOURNAL OF HEMATOLOGY (2009)
Standardization of terminology, definitions and outcome criteria in immune thrombocytopenic purpura of adults and children: report from an international working group
Francesco Rodeghiero et al.
BLOOD (2009)
Preferred Reporting Items for Systematic Reviews and Meta-Analyses: The PRISMA Statement
David Moher et al.
JOURNAL OF CLINICAL EPIDEMIOLOGY (2009)
Rituximab efficacy and. safety in adult splenectomy candidates with chronic immune thrombocytopenic purpura:: results of a prospective multicenter phase 2 study
Bertrand Godeau et al.
BLOOD (2008)
Rituximab therapy in adult patients with relapsed or refractory immune thrombocytopenic purpura: long-term follow-up results
Marta Medeot et al.
EUROPEAN JOURNAL OF HAEMATOLOGY (2008)
The immune thrombocytopenic purpura (ITP) bleeding score: assessment of bleeding in patients with ITP
Lemke K. Page et al.
BRITISH JOURNAL OF HAEMATOLOGY (2007)
Therapy with high-dose dexamethasone (HD-DXM) in previously untreated patients affected by idiopathic thrombocytopenic purpura: a GIMEMA experience
Maria Gabriella Mazzucconi et al.
BLOOD (2007)
Systematic review: Efficacy and safety of rituximab for adults with idiopathic thrombocytopenic purpura
Donald M. Arnold et al.
ANNALS OF INTERNAL MEDICINE (2007)
Earlier administration of Rituximab allows higher rate of long-lasting response in adult patients with autoimmune thrombocytopenia
F Zaja et al.
EXPERIMENTAL HEMATOLOGY (2006)
Splenectomy for adult patients with idiopathic thrombocytopenic purpura: a systematic review to assess long-term platelet count responses, prediction of response, and surgical complications
K Kojouri et al.
BLOOD (2004)
Initial treatment of immune thrombocytopenic purpura with high-dose dexamethasone.
YF Cheng et al.
NEW ENGLAND JOURNAL OF MEDICINE (2003)
分享论文
